Translations:SGLT2 inhibitor/23/ja: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 February 2024

  • curprev 21:1421:14, 12 February 2024 Fire talk contribs 1,194 bytes −2 No edit summary
  • curprev 21:1221:12, 12 February 2024 Fire talk contribs 1,196 bytes +1,196 Created page with "{| class="wikitable" |+ 表2: 様々なSGLT-2阻害剤の薬物動態パラメータ |- ! 薬物名 !! 生物学的利用能 !! タンパク質結合 !! 最大(時間) !! t1/2 (hours) !! Cmax !! SGLT1に対するSGLT2選択性 |- | Canagliflozin/ja || 65% (300 mg dose) || 99% || 1–2 || 10.6 (100 mg dose); 13.1 (300 mg dose) || 1096 ng/mL (100 mg dose); 3480 ng/mL (300 mg dose) || 250 fold |- | Dapagliflozin/ja || 78% || 91..."